The Scientist

» oocyte, immunology and disease/medicine

Most Recent

image: Networking Medicine

Networking Medicine

By | March 2, 2013

Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.

0 Comments

image: Bedeviled by Dengue

Bedeviled by Dengue

By | March 1, 2013

The global spread of dengue virus has immunologists and public-health experts debating the best way to curb infection.

5 Comments

image: Do-It-Yourself Medicine

Do-It-Yourself Medicine

By | March 1, 2013

Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?

9 Comments

image: Stem Cell Trial Nearly Approved

Stem Cell Trial Nearly Approved

By | February 15, 2013

The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.

0 Comments

image: Why Women’s Eggs Don’t Last

Why Women’s Eggs Don’t Last

By | February 13, 2013

As reproductive tissues age, DNA repair mechanisms become less efficient, causing genomic damage to accumulate.

0 Comments

image: Do Mice Make Bad Models?

Do Mice Make Bad Models?

By | February 11, 2013

A study suggests that some mouse models do not accurately mimic human molecular mechanisms of inflammatory response, but other mouse strains may fare better.

4 Comments

image: Stem Cells: Safe Haven For TB

Stem Cells: Safe Haven For TB

By | February 5, 2013

Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.

2 Comments

image: New TB Vaccine Fails Trial

New TB Vaccine Fails Trial

By | February 4, 2013

One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.

1 Comment

image: Opinion: Health Booth 2020

Opinion: Health Booth 2020

By | February 4, 2013

Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.

3 Comments

image: A Chill Issue

A Chill Issue

By | February 1, 2013

The very cold, the merely chilled, and the colorful

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech